Lung Cancer Oncology Account Specialist: Drive Patient Care

AstraZeneca plc; San Francisco (CA); On-site; USD 133,000 - 229,000; Full time

Benefits offered by this job

Short-term incentive bonuses

Equity-based awards (salaried roles)

Commissions for sales roles

Qualified retirement programs

Paid time off

Health insurance

Dental coverage

Vision coverage

Job summary

AstraZeneca in the United States is seeking an Oncology Account Specialist (OAS) – Lung Cancer to engage healthcare professionals through clinical selling, identify education needs, and advance patient care.

You will partner with the Oncology Business Manager to develop and manage account plans, use insights from the tumor patient journey, and collaborate with cross-brand teams to optimize education and engagement.

Qualifications

• 3+ years of Sales or Commercial experience within the healthcare ecosystem.
• Bachelor’s degree.
• A valid driver’s license and safe driving record.

Responsibilities

• Learn account priorities for specific tumor types and local trends relevant to clinical practice.
• Conduct opportunity assessments and identify multi-disciplinary customers within accounts across the patient journey to inform business priorities.
• Develop tumor-focused business plans based on key insights and engagement plans focused on key account partners.
• Work with peer field team members to identify cross-brand engagement opportunities.
• Provide critical input into geography-level priorities and plans.
• Educate and engage HCPs about efficacy, safety, and dosing profiles for FDA-approved indications.
• Educate on approved companion diagnostic tests and importance of appropriate patient identification.

Education

Bachelor’s degree

Job description

AstraZeneca in the United States is seeking an Oncology Account Specialist (OAS) – Lung Cancer to engage healthcare professionals through clinical selling, identify education needs, and advance patient care.

You will partner with the Oncology Business Manager to develop and manage account plans, use insights from the tumor patient journey, and collaborate with cross-brand teams to optimize education and engagement.